Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-26 @ 3:26 AM
Study NCT ID:
NCT04714060
Status:
UNKNOWN
Last Update Posted:
2022-05-18
First Post:
2021-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
UB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the Genitals
Sponsor:
UBP Greater China (Shanghai) Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-10-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-01-15
First Submit QC Date:
None
Study First Post Date:
2021-01-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-16
Last Update Post Date:
2022-05-18
Last Update Post Date Type:
ACTUAL